CIK: 0001674712 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value ($000): $2,845,273 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Instil Bio Inc | 12,486,787 | $313,169 | 11.0% | $25.08 | — | Common | 45783C101 |
| ALXO | ALX Oncology Holdings Inc | 4,220,048 | $311,186 | 10.9% | $39.31 | +100.2% | Common | 00166B105 |
| — | Amyris, Inc | 13,161,847 | $251,391 | 8.8% | $3.12 | — | Common | 03236M200 |
| ASND | Ascendis Pharma A/S | 1,664,242 | $214,488 | 7.5% | $112.61 | — | SPONSORED ADR | 04351P101 |
| — | New Frontier Health Corp | 14,300,000 | $161,590 | 5.7% | $8.25 | — | Ord Shs | G6461G106 |
| HRMY | Harmony Biosciences Holdings Inc | 4,534,341 | $149,815 | 5.3% | $36.46 | -3.8% | Common | 413197104 |
| — | Genetron Holdings Ltd | 6,339,860 | $136,053 | 4.8% | $12.07 | — | ADS | 37186H100 |
| — | Bolt Therapeutics Inc | 3,871,291 | $127,404 | 4.5% | $32.91 | — | Common | 097702104 |
| TARS | Tarsus Pharmaceuticals Inc | 3,245,035 | $104,587 | 3.7% | $28.48 | +29.8% | Common | 87650L103 |
| — | Aligos Therapeutics Inc | 3,547,030 | $80,659 | 2.8% | $27.65 | — | Common | 01626L105 |
| LEGN | Legend Biotech Corp Sponsored | 2,755,007 | $79,950 | 2.8% | $42.56 | — | SPONSORED ADS | 52490G102 |
| — | Essa Pharma Inc | 2,068,907 | $60,102 | 2.1% | $9.69 | — | Common | 29668H708 |
| TERN | Terns Pharmaceuticals Inc | 2,675,133 | $58,853 | 2.1% | $21.92 | 0.0% | Common | 880881107 |
| KALV | KalVista Pharmaceuticals Inc. | 1,863,296 | $47,868 | 1.7% | $15.45 | +70.1% | Common | 483497103 |
| ACRS | Aclaris Therapeutics, Inc. | 1,647,214 | $41,510 | 1.5% | $1.36 | +1336.7% | Common | 00461U105 |
| OLMA | Olema Pharmaceuticals Inc | 1,238,575 | $41,096 | 1.4% | $46.89 | -8.6% | Common | 68062P106 |
| SVA | Sinovac Biotech Ltd. | 5,900,000 | $38,173 | 1.3% | $6.47 | 0.0% | SHS | P8696W104 |
| — | Iveric Bio Inc | 5,966,527 | $36,873 | 1.3% | $5.10 | — | Common | 46583P102 |
| CRNX | Crinetics Pharmaceuticals Inc | 2,214,138 | $33,832 | 1.2% | $20.29 | -23.6% | Common | 22663K107 |
| — | Sierra Oncology, Inc | 1,917,074 | $33,031 | 1.2% | $10.67 | — | Common | 82640U404 |
| NVAX | Novavax Inc | 157,487 | $28,554 | 1.0% | $121.82 | +63.6% | Common | 670002401 |
| CLDX | Celldex Therapeutics Inc | 1,291,875 | $26,613 | 0.9% | $4.95 | +363.9% | Common | 15117B202 |
| — | Avadel Pharmaceuticals PLC | 2,937,093 | $26,551 | 0.9% | $7.94 | — | ADR | 05337M104 |
| — | Verona Pharma PLC ADR | 3,048,507 | $25,486 | 0.9% | $5.20 | — | ADS | 925050106 |
| — | Passage Bio Inc | 1,413,508 | $24,708 | 0.9% | $15.75 | — | Common | 702712100 |
| — | Gracell Biotechnologies Inc | 1,522,994 | $23,454 | 0.8% | $15.40 | — | SPONSORED ADS | 38406L103 |
| ZLAB | Zai Lab Ltd ADR | 175,000 | $23,350 | 0.8% | $76.83 | — | ADR | 98887Q104 |
| — | Kadmon Holdings Inc | 5,817,459 | $22,630 | 0.8% | $4.19 | — | Common | 48283N106 |
| ARQT | Arcutis Biotherapeutics Inc | 744,370 | $21,535 | 0.8% | $26.87 | +16.2% | Common | 03969K108 |
| — | Akero Therapeutics Inc | 673,280 | $19,532 | 0.7% | $22.08 | — | Common | 00973Y108 |
| — | Chinook Therapeutics Inc | 1,206,266 | $18,745 | 0.7% | $15.86 | — | Common | 16961L106 |
| — | Curis Inc | 1,553,500 | $17,586 | 0.6% | $8.50 | — | Common | 231269200 |
| NKTX | Nkarta Inc | 512,225 | $16,852 | 0.6% | $29.47 | +62.1% | Common | 65487U108 |
| CYTK | Cytokinetics Inc | 700,000 | $16,282 | 0.6% | $23.39 | -8.7% | Common | 23282W605 |
| DSGN | Design Therapeutics | 530,991 | $15,877 | 0.6% | $31.14 | 0.0% | Common | 25056L103 |
| — | Eiger BioPharmaceuticals Inc | 1,791,257 | $15,853 | 0.6% | $6.80 | — | Common | 28249U105 |
| KURA | Kura Oncology Inc | 525,262 | $14,849 | 0.5% | $14.42 | +119.3% | Common | 50127T109 |
| MREO | Mereo Biopharma Group PLC | 4,220,938 | $14,225 | 0.5% | $2.68 | — | ADS | 589492107 |
| LRMR | Larimar Therapeutics Inc | 799,662 | $11,683 | 0.4% | $11.65 | +56.0% | Common | 517125100 |
| CGEM | Cullinan Management Inc | 250,000 | $10,418 | 0.4% | $40.60 | 0.0% | Common | 230031106 |
| — | Orchard Therapeutics plc | 1,325,736 | $9,625 | 0.3% | $7.53 | — | ADS | 68570P101 |
| — | Aslan Pharmaceuticals Ltd | 2,840,909 | $9,517 | 0.3% | $3.35 | — | ADS | 04522R101 |
| ARWR | Arrowhead Pharmaceuticals Inc | 137,411 | $9,112 | 0.3% | $40.33 | +92.4% | Common | 04280A100 |
| — | Zymeworks Inc | 286,064 | $9,034 | 0.3% | $35.47 | — | Common | 98985W102 |
| DYN | Dyne Therapeutics Inc | 577,642 | $8,971 | 0.3% | $20.78 | -6.9% | Common | 26818M108 |
| CDXS | Codexis, Inc | 388,144 | $8,885 | 0.3% | $13.98 | +67.4% | Common | 192005106 |
| — | Calliditas Therapeutics ADR | 311,030 | $8,574 | 0.3% | $23.20 | — | SPONSORED ADS | 13124Q106 |
| IMVT | Immunovant Inc | 532,847 | $8,547 | 0.3% | $24.46 | +7.8% | Common | 45258J102 |
| — | Homology Medicines, Inc. | 853,143 | $8,028 | 0.3% | $15.54 | — | Common | 438083107 |
| — | Satsuma Pharmaceuticals Inc | 1,232,394 | $7,283 | 0.3% | $5.91 | — | Common | 80405P107 |
| SNDX | Syndax Pharmaceuticals Inc | 320,000 | $7,155 | 0.3% | $22.59 | 0.0% | Common | 87164F105 |
| AUPH | Aurinia Pharmaceuticals Inc. | 500,732 | $6,502 | 0.2% | $17.64 | -17.7% | Common | 05156V102 |
| — | Kala Pharmaceuticals, Inc. | 786,883 | $5,304 | 0.2% | $8.79 | — | Common | 483119103 |
| ATRC | Atricure Inc | 64,573 | $4,231 | 0.1% | $35.95 | +71.3% | Common | 04963C209 |
| — | Merus NV | 175,000 | $3,656 | 0.1% | $20.89 | — | Common | N5749R100 |
| — | Constellation Pharmaceutical | 140,298 | $3,282 | 0.1% | $31.43 | — | Common | 210373106 |
| TXG | 10X Genomics Inc | 14,798 | $2,678 | 0.1% | $145.11 | +19.0% | CL A Common | 88025U109 |
| — | Zogenix Inc | 105,000 | $2,050 | 0.1% | $22.77 | — | Common | 98978L204 |
| — | VYNE Therapeutics Inc | 234,877 | $1,608 | 0.1% | $1.66 | — | Common | 92941V100 |
| — | IGM Biosciences Inc | 20,000 | $1,534 | 0.1% | $56.15 | — | Common | 449585108 |
| — | Precision Biosciences Inc | 140,255 | $1,452 | 0.1% | $6.03 | — | Common | 74019P108 |
| — | Tricida, Inc. | 174,763 | $924 | 0.0% | $22.00 | — | Common | 89610F101 |
| — | Metacrine Inc | 146,426 | $908 | 0.0% | $10.21 | — | Common | 59101E103 |